Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3C2A | O00443 | 1/20 | 0.33 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24576536 | 0.94 | PIK3C2A (0.32) | PIK3C2APIK3C2BPIK3CAMTOR | |
| SCHEMBL24576630 | 0.89 | TRPM8 (0.33) | PIK3C2APIK3C2BPIK3CAMTORTRPM8 | |
| SCHEMBL24576368 | 0.88 | CYP1A2 (0.32) | TRPM8CYP1A2ALDH1A1 | |
| SCHEMBL24576373 | 0.85 | MEN1 (0.34) | PIK3C2APIK3C2BPIK3CAMTORTRPM8 | |
| SCHEMBL31659089 | 0.84 | POLB (0.36) | PIK3C2APIK3C2BPIK3CAMTORTRPM8 | |
| SCHEMBL24576621 | 0.84 | POLB (0.36) | PIK3C2APIK3C2BPIK3CAMTORTRPM8 | |
| SCHEMBL24576533 | 0.84 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL24576635 | 0.83 | PIK3C2A (0.31) | PIK3C2APIK3C2BPIK3CAMTORCYP1A2 | |
| SCHEMBL17529566 | 0.83 | S1PR1 (0.32) | PIK3C2APIK3C2BPIK3CAMTORS1PR1 | |
| SCHEMBL20393862 | 0.83 | PIK3C2A (0.37) | PIK3C2APIK3C2BPIK3CAMTORTRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220204499-A1 | CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204499-A1 | CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | BCHE, C1R, C1S | PIK3C2A 988/4885PIK3C2B 1537/4885PIK3CA 2282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.